secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-09-15T12:17:35+00:00
Accession:  0001683168-26-007126
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical amends exec severance to lump-sum on change in control for CEO/CFO and CMO
--------------------------------------------------------------------------------

- On Sept 11, 2026, Aethlon amended employment agreements of CEO/CFO James B. Frakes and CMO Steven P. LaRosa.
- Change-in-control severance payments will now be paid as a single lump sum instead of installments.
- Health care continuation payments also become lump-sum, fixed once payable, not reduced by new coverage.
- Amendment does not alter amount, calculation, or eligibility for severance benefits.
- Frakes serves as CEO/CFO; LaRosa as CMO; no changes to their base pay or other terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826007126/0001683168-26-007126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826007126/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer